Adamas Pharmaceuticals Inc (ADMS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
9:55 pm
Sale
2021-12-3113GADAMAS PHARMACEUTICALS INC
ADMS
ARMISTICE CAPITAL LLC0
0.000%
-2,742,000decrease
(Position Closed)
Filing
History
2022-02-11
7:47 pm
Sale
2021-12-3113GADAMAS PHARMACEUTICALS INC
ADMS
Stonepine Capital Management LLC0
0.000%
-3,408,849decrease
(Position Closed)
Filing
History
2022-01-26
11:00 am
Sale
2021-12-3113GADAMAS PHARMACEUTICALS INC
ADMS
Opaleye Management Inc.0
0.000%
-1,487,800decrease
(Position Closed)
Filing
History
2021-12-10
08:52 am
Sale
2021-12-0913GADAMAS PHARMACEUTICALS INC
ADMS
FMR LLC0
0.000%
-4,575,536decrease
(Position Closed)
Filing
History
2021-10-20
3:42 pm
Sale
2021-10-1113GADAMAS PHARMACEUTICALS INC
ADMS
HIRSCHMAN ORIN0
0.000%
-1,611,313decrease
(Position Closed)
Filing
History
2021-10-19
4:26 pm
Purchase
2021-10-1113DADAMAS PHARMACEUTICALS INC
ADMS
Magnetar Financial LLC3,131,937
6.850%
3,131,937increase
(New Position)
Filing
History